Ann: AGM Presentation , page-13

I just returned home and read the AGM announcement.
Whilst Im VERY disappointed to not hear more regarding the urban myth that may or may not be NASDAQ listing, I thought there were a few highlights amongst it all:

-Cvac also has potential indicators in several additional cancers.
-Ovarian cancer, the first target, has the highest mortality of all gynecological cancers.
-Cvac is a potential game changer for treatment of tumors that-over express mucin-1.
-Breast cancer study for Cvac to commence in Q4 2011.
-Company to also develop an oral delivery system for treatment of cervical cancer vaccine.

It seems as if ovarian cancer is just the beginning!
Not sure exactly how many cancers express mucin-1, but if we get a measly 10% market share of each...thats a multi billion dollar Company!!!
They also seem very confident that they WILL develop the oral delivery system for cervical cancer, not if but when! This could/should add SIGNIFICANTLY to the Companys earnings...and testing is progressing well, a fact maybe some observers have missed?
The Newsflow section on page 29 is great too, indicating 2011 is set to be a HUGE year from Prima. Imagine...all this is happening just after we list on the NASDAQ :)
Its pretty easy to see why the SP is (apparently) being manipulated for accumulation!!!
The comparisins with Dendreon will just get stronger and louder in the US, where this sort of stocks potential will be more fully appreciated.

WOW!!! I thought this was a great presentation.
It has strengthened my resolve to not only hold very long term, but to also add to my holdings at this ridiculously low shareprice!

Well done Martin and the team...and welcome aboard Lucy!!!

Sorry for the lengthy post...my opinions only, dyor.